Clinical Trial Update: Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism [Phase 4]

View source ↗

Summary

A Phase 4 trial update comparing finerenone to spironolactone in patients with primary aldosteronism, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• Finerenone (finerenone)
• Spironolactone (spironolactone)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Primary Aldosteronism | Phase 4 | Status: UNKNOWN